Yin-yang actions of histone methylation regulatory complexes in the brain
- PMID: 27855486
- PMCID: PMC5289040
- DOI: 10.2217/epi-2016-0090
Yin-yang actions of histone methylation regulatory complexes in the brain
Abstract
Dysregulation of histone methylation has emerged as a major driver of neurodevelopmental disorders including intellectual disabilities and autism spectrum disorders. Histone methyl writer and eraser enzymes generally act within multisubunit complexes rather than in isolation. However, it remains largely elusive how such complexes cooperate to achieve the precise spatiotemporal gene expression in the developing brain. Histone H3K4 methylation (H3K4me) is a chromatin signature associated with active gene-regulatory elements. We review a body of literature that supports a model in which the RAI1-containing H3K4me writer complex counterbalances the LSD1-containing H3K4me eraser complex to ensure normal brain development. This model predicts H3K4me as the nexus of previously unrelated neurodevelopmental disorders.
Keywords: LSD1; PHF21A; RAI1; activity-dependent gene expression; autism spectrum disorders; chromatin regulatory complex; circadian gene expression; histone methylation; intellectual disability; neurodevelopmental disorders.
Conflict of interest statement
Financial & competing interests disclosure PM Garay is supported collectively by an NSF Graduate Research Fellowship Program (DGE #1256260), the University of Michigan Rackham Spring Summer Research Grant Program and the Farrehi Family Foundation. MA Wallner is supported by the University of Michigan Undergraduate Research Opportunity Program (UROP). This work is also supported by the grants to S Iwase from NIH (NS089896) and the University of Michigan Medical School. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Figures
Similar articles
-
Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation.Commun Biol. 2020 Jun 1;3(1):278. doi: 10.1038/s42003-020-1001-6. Commun Biol. 2020. PMID: 32483278 Free PMC article.
-
Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.Epigenomics. 2015;7(3):503-19. doi: 10.2217/epi.15.1. Epigenomics. 2015. PMID: 26077434 Free PMC article. Review.
-
H3K4 Methylation Dependent and Independent Chromatin Regulation by JHD2 and SET1 in Budding Yeast.G3 (Bethesda). 2018 May 4;8(5):1829-1839. doi: 10.1534/g3.118.200151. G3 (Bethesda). 2018. PMID: 29599176 Free PMC article.
-
Evidence for genetic regulation of mRNA expression of the dosage-sensitive gene retinoic acid induced-1 (RAI1) in human brain.Sci Rep. 2016 Jan 8;6:19010. doi: 10.1038/srep19010. Sci Rep. 2016. PMID: 26743651 Free PMC article.
-
Regulation of histone H3K4 methylation in brain development and disease.Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652):20130514. doi: 10.1098/rstb.2013.0514. Philos Trans R Soc Lond B Biol Sci. 2014. PMID: 25135975 Free PMC article. Review.
Cited by
-
New Insights into Potocki-Shaffer Syndrome: Report of Two Novel Cases and Literature Review.Brain Sci. 2020 Oct 28;10(11):788. doi: 10.3390/brainsci10110788. Brain Sci. 2020. PMID: 33126574 Free PMC article. Review.
-
The histone variant H2A.Z in gene regulation.Epigenetics Chromatin. 2019 Jun 14;12(1):37. doi: 10.1186/s13072-019-0274-9. Epigenetics Chromatin. 2019. PMID: 31200754 Free PMC article. Review.
-
The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.Theranostics. 2021 May 12;11(14):6983-7004. doi: 10.7150/thno.57237. eCollection 2021. Theranostics. 2021. PMID: 34093866 Free PMC article.
-
The H2A.Z and NuRD associated protein HMG20A controls early head and heart developmental transcription programs.Nat Commun. 2023 Jan 28;14(1):472. doi: 10.1038/s41467-023-36114-x. Nat Commun. 2023. PMID: 36709316 Free PMC article.
-
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A.Br J Clin Pharmacol. 2021 Dec;87(12):4756-4768. doi: 10.1111/bcp.14912. Epub 2021 Jun 10. Br J Clin Pharmacol. 2021. PMID: 33990969 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous